| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 26.226 | 59.478 | 73.815 | 88.590 | 100.294 | 117.658 | 132.869 | 176.435 | 195.677 |
| Total Income - EUR | - | 26.226 | 59.479 | 73.816 | 88.590 | 100.294 | 117.658 | 132.870 | 176.435 | 203.679 |
| Total Expenses - EUR | - | 18.467 | 31.093 | 32.874 | 33.659 | 36.216 | 33.154 | 44.989 | 52.244 | 74.175 |
| Gross Profit/Loss - EUR | - | 7.759 | 28.386 | 40.941 | 54.931 | 64.078 | 84.504 | 87.881 | 124.191 | 129.504 |
| Net Profit/Loss - EUR | - | 7.496 | 26.369 | 40.203 | 54.045 | 63.143 | 83.328 | 86.579 | 122.427 | 123.515 |
| Employees | - | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Dr Daniela Porojan Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 16.224 | 12.019 | 8.373 | 4.130 | 1.136 | 830 | 1.162 | 1.429 | 49.821 |
| Current Assets | - | 5.157 | 51.097 | 60.287 | 70.421 | 73.357 | 87.437 | 89.089 | 128.460 | 110.218 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 3.049 | 49.993 | 59.008 | 69.515 | 66.090 | 86.254 | 84.304 | 121.925 | 93.742 |
| Cash | - | 2.107 | 1.104 | 1.279 | 906 | 7.267 | 1.183 | 4.785 | 6.535 | 16.477 |
| Shareholders Funds | - | 7.541 | 26.423 | 40.268 | 54.096 | 63.207 | 83.376 | 86.627 | 122.475 | 123.564 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 14.549 | 37.128 | 29.286 | 20.474 | 11.287 | 4.891 | 3.623 | 7.415 | 36.476 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr Daniela Porojan Medica Srl